Lucius Pharmaceuticals

Ambrisentan: A Treatment for Pulmonary Arterial Hypertension (PAH)

Date:2025-6-27 Views:779

Ambrisentan is a prescription medication used to treat pulmonary arterial hypertension (PAH)—a type of high blood pressure that affects the arteries in the lungs and puts strain on the right side of the heart. It helps improve your ability to exercise and may slow the progression of symptoms.

Ambrisentan: A Treatment for Pulmonary Arterial Hypertension (PAH)
LuciAmb (Ambrisentan) 5mg

Ambrisentan belongs to a class of medications called endothelin receptor antagonists. It works by blocking the effects of a natural substance in the body called endothelin-1, which causes blood vessels to narrow. By preventing this narrowing, Ambrisentan:

  • Relaxes and widens the blood vessels in the lungs
  • Lowers blood pressure in the lungs
  • Reduces the workload on the heart

While many people tolerate Ambrisentan well, some may experience:

  • Swelling in the feet or ankles (fluid retention)
  • Nasal congestion or runny nose
  • Headache
  • Flushing (warmth or redness in the face)
  • Sinus discomfort

Rare but serious side effects can include:

  • Liver problems: Watch for signs like nausea, yellowing of the skin or eyes, or dark-colored urine
  • Anemia: Symptoms may include tiredness or shortness of breath
  • Pregnancy risk: Ambrisentan can harm unborn babies and should not be used during pregnancy

Safety and Monitoring

To ensure safe use, your doctor may recommend:

  • Regular blood tests to monitor liver function and red blood cell levels
  • Reliable birth control for women of childbearing age

Do not stop taking Ambrisentan without consulting your healthcare provider.

Conclusion

Ambrisentan offers hope for people living with PAH by helping improve daily function and quality of life. Your medical team will work closely with you to ensure the treatment is effective and safe.

Ambrisentan: A Treatment for Pulmonary Arterial Hypertension (PAH)
GMP Certificate of Lucius Pharmaceuticals

Original article, if reprinted, please indicate the link to this article: https://lucius-pharmaceuticals.com/ambrisentan-a-treatment-for-pulmonary-arterial-hypertension-pah/

Related News